Lipocine第二季度每股收益$（0.41）低于$（0.40）估计，销售额为6.22849亿美元，超过22.9万美元估计

Lipocine (NASDAQ: LPCN) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.40) by 2.5 percent. This is a 26.79 percent increase over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $622.849 million which beat the analyst consensus estimate of $229.000 thousand by 271.89K percent. This is a 695.32K percent increase over sales of $89.565 thousand the same period last year.